| List of Principal Authors | p. ix |
| Preface | p. xiii |
| IBD and Genetics | |
| Relevant genes in IBD | p. 3 |
| Epidemiological aspects of IBD | p. 15 |
| HLA-antigens in IBD | p. 20 |
| Autoantibodies in IBD | p. 27 |
| Experimental Models of IBD | |
| Experimental models of IBD: old hypotheses confirmed and new paradigms generated | p. 35 |
| Neuroimmune interactions in IBD | p. 43 |
| Interleukin-12 and anti-interleukin-12 | p. 47 |
| Spontaneous colitis and gastritis in HLA-B27/[beta subscript 2]-microglobulin transgenic rats and its association with normal luminal bacteria | p. 52 |
| Basic Concepts of Mucosal Immunology | |
| Mucosal immune system: an overview | p. 63 |
| Effector mechanisms in intestinal immunity and inflammation | p. 74 |
| Homing of mucosally activated lymphocytes in humans | p. 84 |
| Principles of oral tolerance | p. 90 |
| Immunological tolerance in IBD | p. 100 |
| IBD and Immunology | |
| Intestinal macrophages | p. 111 |
| Role of fibroblasts in inflammatory bowel disease | p. 120 |
| The role of extracellular matrix proteins in IBD | p. 129 |
| Heat shock proteins in IBD | p. 136 |
| Regulation and function of eosinophils and mast cells: implications for the gastrointestinal tract | p. 143 |
| Epithelial Barrier in IBD | |
| Role of epithelial cells in IBD | p. 155 |
| Cytokines and intestinal epithelial cells | p. 173 |
| Gastrointestinal permeability in Crohn's disease -- clinical relevance | p. 183 |
| Injury and healing in the epithelium | p. 188 |
| Endotoxin and IBD | |
| Detection of endotoxin in IBD | p. 199 |
| Diagnosis of IBD | |
| Radiological investigation of IBD | p. 219 |
| The pancreas in Crohn's disease | p. 228 |
| Colonoscopy and laparoscopy in Crohn's disease in children | p. 233 |
| IBD and Malignancy | |
| IBD: intestinal cancer risk and surveillance | p. 239 |
| Role of flow cytometry in surveillance strategies in patients with ulcerative colitis | p. 243 |
| K-ras and p53 mutations in colonic lavage fluid of patients with long-standing IBD | p. 254 |
| The impact of therapy on colorectal cancer in ulcerative colitis | p. 261 |
| Therapy in IBD | |
| Therapeutic concepts in IBD | p. 267 |
| Salicylates | p. 276 |
| Glucocorticosteroids in the treatment of IBD | p. 289 |
| Immunosuppressive therapy | p. 297 |
| Monoclonal antibodies and interleukins | p. 304 |
| Antibiotic therapy in Crohn's disease | p. 311 |
| Alternative therapeutic approaches in IBD | p. 317 |
| Endoscopic therapy | p. 328 |
| Surgical therapy of Crohn's disease | p. 333 |
| Surgical therapy in ulcerative colitis with special reference to restorative proctocolectomy | p. 339 |
| Index | p. 351 |
| Table of Contents provided by Syndetics. All Rights Reserved. |